Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Donald A. Bergstrom files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
- Thomas Catinazzo - $4.83M of RLAY open-market activity in the last 12 months
- Sanjiv Patel - $2.70M of RLAY open-market activity in the last 12 months
- Peter Rahmer - $1.46M of RLAY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Donald A. Bergstrom?
Donald A. Bergstrom is a corporate insider, tracked as President, R&D of Relay Therapeutics, Inc. (RLAY). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Donald A. Bergstrom submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Donald A. Bergstrom been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($2.32M) across all tracked filings.
Where can I see all of Donald A. Bergstrom's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Donald A. Bergstrom and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
